Skip to main content

Anika Therapeutics, Inc 10-K for FY2021

Anika Therapeutics, Inc. (ANIK)

10-K 2022-03-11 For: 2021-12-31
View Original
Added on April 06, 2026

About this 10-K

Anika Therapeutics, Inc filed this 10-K on March 11, 2022, covering the fiscal year ended December 31, 2021 (FY2021).

Headline figures

Fiscal year ended December 31, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$147.79M
up 13.3% from $130.46M a year earlier
Net income
$4.13M
compared with a net loss of $23.98M a year earlier
Diluted EPS
$0.28
compared with -$1.69 a year earlier